日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

Durvalumab联合Tremelimumab和立体定向放射治疗转移性头颈癌的I/II期临床试验

Bahig, Houda; Aubin, Francine; Stagg, John; Gologan, Olguta; Ballivy, Olivier; Bissada, Eric; Nguyen-Tan, Felix-Phuc; Soulières, Denis; Guertin, Louis; Filion, Edith; Christopoulos, Apostolos; Lambert, Louise; Tehfe, Mustapha; Ayad, Tareck; Charpentier, Danielle; Jamal, Rahima; Wong, Philip